We recently demonstrated that tumor-reactive human T cells from patients with cancer express the costimulatory molecule CD137 (4-1BB) in an activation-induced manner allowing for the rapid identification of recently antigen-activated T cells ex vivo [23]. The gene discussed is TNFRSF9; the disease is cancer.